185 related articles for article (PubMed ID: 15339672)
1. No increase in age-specific incidence of myelodysplastic syndromes.
Germing U; Strupp C; Kündgen A; Bowen D; Aul C; Haas R; Gattermann N
Haematologica; 2004 Aug; 89(8):905-10. PubMed ID: 15339672
[TBL] [Abstract][Full Text] [Related]
2. [Evolutive epidemiologic profile of myelodysplastic syndromes (1959-1993). Comparative study with acute myeloid leukemia and aplastic pancytopenias].
Sánchez Fayos J; Outeiriño Pérez JJ; Prieto E; Román A; Olavarría E; Cabello A; Soto C; Calabuig T; Paniagua C; Sanz B
Sangre (Barc); 1994 Dec; 39(6):441-8. PubMed ID: 7855696
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndromes (MDS) in Central Africans.
Mukiibi JM; Paul B
Trop Geogr Med; 1994; 46(1):17-9. PubMed ID: 8165730
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
5. Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry.
Neukirchen J; Schoonen WM; Strupp C; Gattermann N; Aul C; Haas R; Germing U
Leuk Res; 2011 Dec; 35(12):1591-6. PubMed ID: 21708407
[TBL] [Abstract][Full Text] [Related]
6. [Myelodisplasic syndromes diagnosed in a geriatric hospital: morphological profile in 100 patients].
Dewulf G; Gouin I; Pautas E; Gaussem P; Chaïbi P; Andreux JP; Siguret V
Ann Biol Clin (Paris); 2004; 62(2):197-202. PubMed ID: 15047472
[TBL] [Abstract][Full Text] [Related]
7. [Alteration of methylation status of fragile histidine triad gene promoter in patients with myelodysplastic syndrome].
Yao DM; Qian J; Xu WR; Lin J; Jiang YW; Fei X; Han LX; Wang Y; Cen JN; Chen ZX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):36-9. PubMed ID: 18247301
[TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes: incidence and survival in the United States.
Ma X; Does M; Raza A; Mayne ST
Cancer; 2007 Apr; 109(8):1536-42. PubMed ID: 17345612
[TBL] [Abstract][Full Text] [Related]
9. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
[TBL] [Abstract][Full Text] [Related]
10. Clinical, hematological and histomorphological profile of myelodysplastic syndrome.
Nigam S; Rani S; Singh T; Gupta S; Rakheja D; Gaiha M
J Assoc Physicians India; 2001 Apr; 49():430-4. PubMed ID: 11762613
[TBL] [Abstract][Full Text] [Related]
11. French registry of acute leukemia and myelodysplastic syndromes. Age distribution and hemogram analysis of the 4496 cases recorded during 1982-1983 and classified according to FAB criteria. Groupe Francais de Morphologie Hematologique.
Cancer; 1987 Sep; 60(6):1385-94. PubMed ID: 3476180
[TBL] [Abstract][Full Text] [Related]
12. Leukemia incidence following primary breast carcinoma treatment.
Kaplan HG; Malmgren JA; Atwood M
Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.
Wulfert M; Küpper AC; Tapprich C; Bottomley SS; Bowen D; Germing U; Haas R; Gattermann N
Exp Hematol; 2008 May; 36(5):577-86. PubMed ID: 18439489
[TBL] [Abstract][Full Text] [Related]
14. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.
Aul C; Gattermann N; Schneider W
Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819
[TBL] [Abstract][Full Text] [Related]
15. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing U; Strupp C; Kuendgen A; Isa S; Knipp S; Hildebrandt B; Giagounidis A; Aul C; Gattermann N; Haas R
Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
[TBL] [Abstract][Full Text] [Related]
16. [Myelodysplastic syndromes. The epidemiological and etiological aspects].
Aul C; Gattermann N; Germing U; Runde V; Heyll A
Dtsch Med Wochenschr; 1992 Aug; 117(33):1223-31. PubMed ID: 1499520
[TBL] [Abstract][Full Text] [Related]
17. Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions.
Hasle H; Kerndrup G; Jacobsen BB
Leukemia; 1995 Sep; 9(9):1569-72. PubMed ID: 7658725
[TBL] [Abstract][Full Text] [Related]
18. Expression of type 1 insulin-like growth factor receptor in marrow nucleated cells in malignant hematological disorders: correlation with apoptosis.
Qi H; Xiao L; Lingyun W; Ying T; Yi-Zhi L; Shao-Xu Y; Quan P
Ann Hematol; 2006 Feb; 85(2):95-101. PubMed ID: 16328478
[TBL] [Abstract][Full Text] [Related]
19. Epidemiological data on myelodysplastic syndrome patients under 50 years in a single center of Romania.
Gologan R
Leuk Res; 2010 Nov; 34(11):1442-6. PubMed ID: 20189246
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological data from the registry of patients with myelodysplastic syndrome in a single hospital center of Romania.
Gologan R; Georgescu D; Tatic A; Radulescu I; Vasilache D
Leuk Res; 2009 Nov; 33(11):1556-61. PubMed ID: 19411107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
